In glioma, the cancer genome atlas (TCGA) data showed that cytosolic NADP+-dependent isocitrate dehydrogenase 1 (IDH1) mutation tumors represent an attenuated level of PD-L1 expression accompanied by higher PD-L1 gene promoter methylation (75, 76). This evidence concerns the gene CD274 and central nervous system cancer.